Eucardia Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Investors
  • 2

Eucardia General Information


Developer of an innovative medical device designed to provide advanced heart failure therapy. The company's innovative medical device is a minimally invasive implantable cardiac device, enabling patients to have improved duration and quality of life and reduced healthcare costs for their assistance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Therapeutic Devices
Primary Office
  • Via G. Leopardi, 7
  • 20123 Milan
  • Italy

Eucardia Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Eucardia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 01-Aug-2019 00.000 Completed Startup
4. Grant 23-Oct-2018 000.00 00.000 Completed Startup
3. Secondary Transaction - Private 00.000 00.000 Completed Startup
2. Grant 01-Dec-2016 $372K $1.09M Completed Startup
1. Early Stage VC $1.09M $1.09M Completed Startup

Eucardia Executive Team (3)

Name Title Board Seat Contact Info
Marco Bottaro Chief Executive Officer
Roberto Parravicini Co-Founder and Chief Scientific Officer
Francesca Parravicini Co-Founder & Executive of Investor relations and corporate communications

Eucardia Investors (2)

To view Eucardia‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Premio Gaetano Marzotto Other 000 0000 000000 0

Ready to get started?

Request a free trial